Literature DB >> 16443434

A speculation about hypercholesterolemia in congenital analbuminemia.

Stefan Rosipal1, Marianna Debreová, Rastislav Rosipal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16443434     DOI: 10.1016/j.amjmed.2005.10.038

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  4 in total

1.  Genome-wide association study identifies multiple loci influencing human serum metabolite levels.

Authors:  Johannes Kettunen; Taru Tukiainen; Antti-Pekka Sarin; Alfredo Ortega-Alonso; Emmi Tikkanen; Leo-Pekka Lyytikäinen; Antti J Kangas; Pasi Soininen; Peter Würtz; Kaisa Silander; Danielle M Dick; Richard J Rose; Markku J Savolainen; Jorma Viikari; Mika Kähönen; Terho Lehtimäki; Kirsi H Pietiläinen; Michael Inouye; Mark I McCarthy; Antti Jula; Johan Eriksson; Olli T Raitakari; Veikko Salomaa; Jaakko Kaprio; Marjo-Riitta Järvelin; Leena Peltonen; Markus Perola; Nelson B Freimer; Mika Ala-Korpela; Aarno Palotie; Samuli Ripatti
Journal:  Nat Genet       Date:  2012-01-29       Impact factor: 38.330

2.  Congenital analbuminemia with acute glomerulonephritis: a diagnostic challenge.

Authors:  Rachel Becker-Cohen; Ruth Belostotsky; Efrat Ben-Shalom; Sofia Feinstein; Choni Rinat; Yaacov Frishberg
Journal:  Pediatr Nephrol       Date:  2008-09-13       Impact factor: 3.714

3.  Treatment of a patient with congenital analbuminemia with atorvastatin and albumin infusion.

Authors:  Maria Del Ben; Francesco Angelico; Lorenzo Loffredo; Francesco Violi
Journal:  World J Clin Cases       Date:  2013-04-16       Impact factor: 1.337

Review 4.  Phenotypic reversion in analbuminemic rats due to an altered splicing mechanism.

Authors:  Hiroyasu Esumi; Takashi Sugimura
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2007-05       Impact factor: 3.493

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.